ep547
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 7, 2020 (NCT04510090)
Timeline
Indications
Mechanism of action
antagonist - MRGPRX4
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05525520 | Phase 2 | Oct 6, 2022 | Escient Pharmaceuticals, Inc |
| NCT04510090 | Phase 1 | Sep 7, 2020 | Escient Pharmaceuticals, Inc, Novotech |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Escient Pharmaceuticals, Inc | For profit | 2 | 2 | 2 | 2020 |
| Novotech | For profit | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1